Constantinos Zamboglou

Constantinos Zamboglou is a radiation oncologist who treats prostate cancer. He is a member of the ESTRO-ACROP guideline committee and the German expert panel for prostate cancer. Zamboglou currently holds leadership roles at the German Medical Institute in Cyprus and the University of Freiburg.

Specialization and Oncology Focus

Zamboglou treats patients using interventional radiation oncology and precision methods for prostate cancer. He uses specialized techniques to target tumors while sparing healthy tissue. He performs several procedures:

• Brachytherapy for prostate cancer — a treatment that puts radioactive sources inside the body to kill cancer cells
• CyberKnife robotic radiosurgery — a non-invasive treatment that delivers high-dose radiation with sub-millimeter precision
• Targeted and hormone therapy
• Immunotherapy and chemotherapy
• Stereotactic Body Radiotherapy (SBRT)

Professional Career

• Since 2022 – Vice Medical Director at the German Medical Institute (GMI) in Limassol, Cyprus.
• Since 2022 – Prostate cancer research group leader at the Medical Center University of Freiburg.
• 2021–2022 – Advanced Clinician Scientist in the Bertha-Ottenstein program at Freiburg.
• 2021 – Head of the Section of Interventional Radiation Oncology at University of Freiburg.
• Since 2019 – Consultant at the Department of Radiation Oncology, University of Freiburg.
• 2017–2020 – Clinician Scientist at the Bertha-Ottenstein program, University of Freiburg, Germany.
• 2013–2019 – Resident at the Medical Center University of Freiburg.

Education and Training

• 2021–2023 – Master of Health Business Administration (MHBA) at Friedrich Alexander University, Germany.
• 2022 – ISO 9001:2015 quality management training in Nicosia, Cyprus.
• 2020 – Habilitation in Radiation Oncology at the University of Freiburg.
• 2019 – Board certification in Radiotherapy and Radiation Oncology.
• 2018 – German drug law and Good Clinical Practice (GCP) training at University of Freiburg.
• 2012 – Doctoral thesis at the Institute of Pharmacology and Toxicology I, Freiburg, awarded summa cum laude.
• 2008–2013 – Medical degree from Albert-Ludwigs-Universität Freiburg, Germany.
• 2006–2008 – Medical studies at Semmelweis University Budapest, Hungary.

Awards and Recognition

• 2023 – Annual ARO study prize from the German Cancer Foundation for the HypoFocal-SBRT study.
• 2021 – Best Abstract award at the EMUC congress in Athens, Greece.
• 2020 – Herman-Holthusen Award from the German Society of Radiation Oncology (DEGRO).
• 2019 – Poster prize at the Uro-Oncological Symposium in Magdeburg.
• 2017 – Poster prize at the DEGRO annual meeting in Berlin.
• 2010 – Sanofi-Aventis poster prize at the German Society of Pharmacology annual meeting in Mainz.

Professional Memberships

• Invited member of the ESTRO-ACROP guideline committee for prostate cancer.
• Member of the German expert panel for prostate cancer of DEGRO.
• Invited member of the ESTRO focus group “Urology”.
• Degree in Television Direction from ANT1 Movie School Athens (2006).